It has been found to act as a novel lymphatic enhancer factor/T cell factor (LEF1/TCF)-associated transcriptional repressor and is a putative tumor suppressor in chronic lymphocytic leukemia [9]. This evidence concerns the gene HNF4A and B-cell chronic lymphocytic leukemia.